Monsanto Aktie
WKN: 578919 / ISIN: US61166W1018
29.06.2016 14:52:58
|
Monsanto Adjusts FY16 Earnings Outlook; Q3 Profit Misses Estimates
(RTTNews) - Monsanto Company (MON) announced the company now expects fiscal 2016 as-reported EPS to be at the low end of the $3.36 to $4.14 adjusted range. In April, the company projected its fiscal 2016 as-reported earnings guidance to be in a range of $3.72 to $4.48 per share. The company adjusted its full-year as-reported EPS guidance range to reflect the Argentina-related tax matters and a favorable change in the expected amount and timing of restructuring expense.
Monsanto now anticipates being at low ends of its fiscal 2016 ongoing EPS guidance range of $4.40 to $5.10 given increased headwinds in third-quarter. The company remains on-track to deliver $165 million to $210 million in savings from its restructuring actions in fiscal year 2016, primarily benefiting operating expenses.
Looking ahead to fiscal 2017, assuming relatively stable currencies, the company expects a return to growth in EPS. The company targets mid-teens compounded annual EPS growth rate from the end of fiscal 2017 to fiscal 2021.
Hugh Grant, CEO, said: "While there is no formal update on the Bayer proposal, I have been personally in discussions with Bayer's management over the last several weeks, along with others regarding alternative strategic options."
Monsanto reported that its third-quarter net income to company decreased to $717 million from $1.14 billion, prior year. EPS on an as-reported basis was $1.63 compared to $2.39, prior year. EPS on an ongoing basis was $2.17, which excludes $0.54 for restructuring charges, environmental and litigation matters and a net charge of $219 million for tax matters related to the Argentina business. On average, 17 analysts polled by Thomson Reuters expected the company to report profit per share of $2.40 for the quarter. Analysts' estimates typically exclude special items.
The company said its third-quarter EPS performance was negatively affected year-over-year by the absence of the Scott's licensing agreement, glyphosate pricing declines, Roundup Ready 2 Xtend launch delay costs and lower soybean volume due to the delay, and India cotton pricing regulations.
Net sales for the third quarter were $4.19 billion versus $4.58 billion in the prior year period. Analysts expected revenue of $4.49 billion for the quarter.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Monsanto Co.mehr Nachrichten
Keine Nachrichten verfügbar. |